Evaluating Meningioma Risk in Users of Estro-Progestin and Progestin-only Therapies: Insights from EudraVigilance Pharmacovigilance Data
A pharmacovigilance study using EudraVigilance data highlights potential safety signals linking desogestrel-only and drospirenone-only hormonal therapies with meningioma, underscoring the need for further longitudinal research and cautious evaluation of long-term hormonal treatment risks.



